HALO - Halozyme Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

HALO is currently covered by 9 analysts with an average price target of $79.06. This is a potential upside of $7.24 (10.08%) from yesterday's end of day stock price of $71.82.

Halozyme Therapeutics's activity chart (see below) currently has 159 price targets and 159 ratings on display. The stock rating distribution of HALO is 75.38% BUY and 24.62% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 88.49% with an average time for these price targets to be met of 293.84 days.

Highest price target for HALO is $91, Lowest price target is $53, average price target is $67.33.

Most recent stock forecast was given by VIKRAM PUROHIT from MORGAN STANLEY on 18-Aug-2025. First documented stock forecast 02-Aug-2012.

Currently out of the existing stock ratings of HALO, 49 are a BUY (75.38%), 16 are a HOLD (24.62%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$80

$8.18 (11.39%)

$75

5 days ago
(18-Aug-2025)

6/8 (75%)

$11.04 (16.01%)

287

Hold

$63

$-8.82 (-12.28%)

$60

16 days ago
(07-Aug-2025)

10/10 (100%)

$0.9 (1.45%)

77

Buy

$91

$19.18 (26.71%)

$73

17 days ago
(06-Aug-2025)

9/13 (69.23%)

$28.68 (46.02%)

430

Buy

$75

$3.18 (4.43%)

$72

17 days ago
(06-Aug-2025)

27/31 (87.1%)

$12.68 (20.35%)

183

Hold

$55

$-16.82 (-23.42%)

$44

1 months 13 days ago
(10-Jul-2025)

2/3 (66.67%)

$-2.63 (-4.56%)

101

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is HALO (Halozyme Therapeutics) average time for price targets to be met?

On average it took 293.84 days on average for the stock forecasts to be realized with a an average price target met ratio 88.49

Which analyst has the current highest performing score on HALO (Halozyme Therapeutics) with a proven track record?

VIKRAM PUROHIT

Which analyst has the most public recommendations on HALO (Halozyme Therapeutics)?

Vikram Purohit works at MORGAN STANLEY and has 5 price targets and 1 ratings on HALO

Which analyst is the currently most bullish on HALO (Halozyme Therapeutics)?

Jason Butler with highest potential upside - $19.18

Which analyst is the currently most reserved on HALO (Halozyme Therapeutics)?

Eun Yang with lowest potential downside - -$58.82

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?